Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Andy Darlington: Randomized Evidence for Catheter-Based Treatment of Intermediate-High-Risk PE
Sep 15, 2026, 14:43

Andy Darlington: Randomized Evidence for Catheter-Based Treatment of Intermediate-High-Risk PE

Andy Darlington, Global Partnerships Manager of Medical Devices at Radcliffe Group, shared a post on LinkedIn:

“In this clip, Prof Lukas Hobohm reviews the findings from the HI-PEITHO randomised controlled trial.

The trial compared EKOS plus anticoagulation with anticoagulation alone in 544 patients with intermediate-high-risk PE, assessing whether intervention could reduce early PE-related complications.

The discussion explores the reduction in the composite outcome of PE-related mortality, cardiopulmonary decompensation or PE recurrence within seven days, alongside findings on major bleeding and hospital length of stay.

Watch the clip below for insights into how randomised evidence is shaping treatment strategies for intermediate-high-risk PE.”

Proceed to the video attached to the post.

Stay updated with Hemostasis Today.